Fresh results from the international INDIGO study offer real optimism for people living with low-grade glioma

The latest follow-up data show that Vorasidenib not only helps slow tumour growth, but also allows patients to maintain their quality of life, preserve memory and thinking skills, and even experience fewer seizures.

With these promising findings, Vorasidenib represents an exciting step forward in giving people more time — and better time — living well after diagnosis.

Click here to download our resource detailing how Vorasidenib could improve the quality of life for people taking it.

Make sure to also read our previous coverage of Vorasidenib, ‘NICE’s latest draft guidance on Vorasidenib is not a final decision.’